Catamaran Corp. CTRX has been awarded
Specialty Pharmacy Accreditation from URAC, a Washington, D.C.-based accrediting organization that
establishes quality standards for the healthcare industry.
"BriovaRx's robust offerings focus on the patient, ensuring one-on-one
support and a personalized plan that addresses chronic conditions to
help them lead healthy, vibrant lives," said Mark Thierer, Chairman and
CEO of Catamaran. "The URAC accreditation is a reflection of BriovaRx's
patient-centric approach that coordinates the efforts of providers,
payers and manufacturers to keep treatments personalized and
successful."
Designed as a better alternative to other specialty pharmacy offerings,
BriovaRx is a high-touch, comprehensive care system of pharmacological
care where patients with chronic illnesses and complex diseases receive
expert therapy management and support tailored to their individual
needs.
URAC made the decision to develop a Specialty Pharmacy accreditation
program because it is one of the key distribution channels for pharmacy
benefit management and extends URAC's consumer protection and
empowerment efforts in managed care pharmacy. URAC offers the only
third-party, voluntary accreditation program of this scope for pharmacy
benefit management and prescription services
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in